Measurement of some serum cytokines in nasal polyp and evaluation of its correlation with disease severity
European Archives of Oto-Rhino-Laryngology, cilt.278, sa.9, ss.3345-3349, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 278 Sayı: 9
- Basım Tarihi: 2021
- Doi Numarası: 10.1007/s00405-020-06600-9
- Dergi Adı: European Archives of Oto-Rhino-Laryngology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.3345-3349
- Anahtar Kelimeler: Interleukin-13, Interleukin-25, Interleukin-33, Nasal polyp, Syndecan-1
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Purpose: Nasal polyp is originating from the nasal mucosa or paranasal sinus mucosa. In our study, it was aimed to investigate the possible effects of inflammatory cytokines Interleukin-13 (IL-13), IL-25, IL-33 and Syndecan-1 (SDC-1) in the pathogenesis process of nasal polyp and relationship between these parameters and disease severity. Methods: Our study was designed as a prospective case–control study. Patients diagnosed with nasal polyp were included in the patient group. The control group comprised volunteers with age and gender compatibility who does not have the disease. IL-13, IL-25, IL-33 and SDC-1 levels were detected in serum samples using enzyme-linked immunosorbent assay method. Nasal polyp disease severity was evaluated by means of “Sino-Nasal Outcome Test-22”, “Lund–Mackay Score” and “Lund–Kennedy Score”. Results: In this study, 35 patients, 29 controls, a total of 64 participants were included. Our evaluation revealed that all cytokine levels in the patient group were statistically significantly higher than the control group (p < 0.05). However, there was no correlation found between scoring methods and cytokine levels (p > 0.05). Conclusion: The increase in cytokine levels in the patient group suggested that cytokine-mediated inflammation processes may be effective in nasal polyp pathogenesis.